TECNIS ODYSSEY IOL DRN00V (REF DRN00V0115)Recalls & reported problems
Johnson & Johnson Surgical Vision, Inc. · TECNIS ODYSSEY SIMPLICITY 11.5D · Class 3 · Implant
All models of TECNIS ODYSSEY IOL (49)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 05050474810594), received between Sep 17, 2024 and Jan 7, 2026 — classified as 2 injuries, 3 malfunctions.
The most frequently reported specific device problem is “Material Split, Cut or Torn” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Material Split, Cut or Torn2
- Scratched Material1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
- Blurred Vision2
- Flashers1
- Halo1
- Visual Disturbances1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjuryJan 7, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PRELOADED JOHNSON AND JOHNSON (JNJ) INTRAOCULAR LENS (IOL) WAS IMPLANTED INTO THE PATIENT¿S RIGHT EYE. DURING A POST-OPERATIVE EXAMINATION, THE PATIENT REPORTED VISUAL DISTURBANCES, INCLUDING SHADOWS OR "AURAS" AROUND LETTERS AND WORDS, UNCLEAR DISTANCE AND NEAR VISION, DIFFICULTY READING, HALOS AROUND LIGHTS, AND GLARE. THE PATIENT¿S PRE-OPERATIVE VISION WAS RECORDED AS 20/50 - 2, WHILE POST-OPERATIVE VISION WAS NOTED AS 20/30. MEDICAL ATTENTION WAS SOUGHT, AND PREDNISOLONE ACETATE WAS PRESCRIBED. THE IOL WAS SUBSEQUENTLY EXPLANTED. THERE WERE NO SUTURES OR VITRECTOMY REQUIRED. NO FURTHER INFORMATION IS AVAILABLE REGARDING THIS EVENT.
Patient problems: Blurred Vision; Flashers; Halo; Visual Disturbances
MAUDE report 23999100 ↗MalfunctionOct 16, 2025Material Split, Cut or Torn; Material Split, Cut or Torn
IT WAS REPORTED THAT TWO SINGLE PIECE PRELOADED MULTIFOCAL INTRAOCULAR LENSES (IOL) TORE DURING INSERTION INTO THE PATIENT¿S LEFT EYE. BOTH LENSES WERE FULLY INSERTED AND THEN CUT IN HALF IN THE EYE AND REMOVED DURING THE SAME PROCEDURE. THIS LED TO A DELAY IN THE PROCEDURE BY APPROXIMATELY 15-20 MINUTES. NO MEDICATION OUTSIDE THE STANDARD OF CARE WAS REQUIRED. THERE WAS NO UNPLANNED INCISION ENLARGEMENT, UNPLANNED VITRECTOMY, OR UNPLANNED SUTURES. NO PATIENT INJURY WAS REPORTED. DAILY ACTIVITIES WERE NOT AFFECTED. THE PATIENT¿S STATUS FOLLOWING THE EVENT IS UNKNOWN. NO FURTHER INFORMATION WAS PROVIDED. THIS REPORT IS TO CAPTURE THE EVENT FOR DRN00V 11.5 DIOPTER, SERIAL NUMBER (B)(6). A SEPARATE REPORT WILL BE FILED TO CAPTURE THE EVENT FOR DRN00V 11.5 DIOPTER, SERIAL NUMBER (B)(6).
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23317894 ↗MalfunctionOct 16, 2025Material Split, Cut or Torn; Material Split, Cut or Torn
IT WAS REPORTED THAT TWO SINGLE PIECE PRELOADED MULTIFOCAL INTRAOCULAR LENSES (IOL) TORE DURING INSERTION INTO THE PATIENT¿S LEFT EYE. BOTH LENSES WERE FULLY INSERTED AND THEN CUT IN HALF IN THE EYE AND REMOVED DURING THE SAME PROCEDURE. THIS LED TO A DELAY IN THE PROCEDURE BY APPROXIMATELY 15-20 MINUTES. NO MEDICATION OUTSIDE THE STANDARD OF CARE WAS REQUIRED. THERE WAS NO UNPLANNED INCISION ENLARGEMENT, UNPLANNED VITRECTOMY, OR UNPLANNED SUTURES. NO PATIENT INJURY WAS REPORTED. DAILY ACTIVITIES WERE NOT AFFECTED. THE PATIENT¿S STATUS FOLLOWING THE EVENT IS UNKNOWN. NO FURTHER INFORMATION WAS PROVIDED. THIS REPORT IS TO CAPTURE THE EVENT FOR DRN00V 11.5 DIOPTER, SERIAL NUMBER (B)(6). A SEPARATE REPORT WILL BE FILED TO CAPTURE THE EVENT FOR DRN00V 11.5 DIOPTER, SERIAL NUMBER (B)(6).
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23317862 ↗InjuryMay 8, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT FOLLOWING THE PRELOADED INTRAOCULAR LENS (IOL) IMPLANTATION IN THE PATIENT'S RIGHT EYE, THE PATIENT COMPLAINED OF BEING UNABLE TO SEE WELL AT A DISTANCE. THE IOL WAS EXPLANTED AND A SYNERGY IOL WAS IMPLANTED. NO PATIENT INJURY WAS REPORTED. NO OTHER MEDICAL INTERVENTION WAS REQUIRED. NO FURTHER INFORMATION WAS PROVIDED.
Patient problems: Blurred Vision
MAUDE report 21988748 ↗MalfunctionSep 17, 2024Scratched Material; Scratched Material
IT WAS REPORTED THAT THE PRELOADED INTRAOCULAR LENS(IOL) WAS IMPLANTED AND THE LENS CAME OUT SCRATCHED OR WITH MARKS ON IT IN THE EYE. THE LENS WAS REMOVED AND REPLACED WITH THE THE BACK UP LENS IN THE SAME PROCEDURE. NO OTHER INFORMATION IS AVAILABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20242389 ↗
Other Lens, multifocal intraocular devices
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular144 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular1 recall66 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular113 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular112 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular110 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular107 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular104 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular93 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page